{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:56:22Z","timestamp":1773291382650,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1038\/nm1101-1202","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:31:14Z","timestamp":1027672274000},"page":"1202-1208","source":"Crossref","is-referenced-by-count":146,"title":["Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy"],"prefix":"10.1038","volume":"7","author":[{"given":"Ben","family":"Wielockx","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrien","family":"Lannoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven D.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyoshi","family":"Itohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00ebl","family":"Vandekerckhove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Libert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnm11011202_CR1","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/00042737-199909000-00005","volume":"11","author":"W Bernal","year":"1999","unstructured":"Bernal, W. & Wendon, J. Acute liver failure; clinical features and management. Eur. J. Gastroenterol. Hepatol. 11, 977\u2013984 (1999).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnm11011202_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0168-8278(99)80368-7","volume":"31","author":"P Marcellin","year":"1999","unstructured":"Marcellin, P. Hepatitis C: The clinical spectrum of the disease. J. Hepatol. 31, 9\u201316 (1999).","journal-title":"J. Hepatol."},{"key":"BFnm11011202_CR3","first-page":"240","volume":"21","author":"JH Hoofnagle","year":"1995","unstructured":"Hoofnagle, J.H., Carithers, R.L. Jr, Shapiro, C. & Ascher, N. Fulminant hepatic failure: summary of a workshop. Hepatology. 21, 240\u2013252 (1995).","journal-title":"Hepatology."},{"key":"BFnm11011202_CR4","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1084\/jem.179.3.841","volume":"179","author":"R Gonzalez\u2013Amaro","year":"1994","unstructured":"Gonzalez\u2013Amaro, R. et al. Induction of tumor necrosis factor \u03b1 production by human hepatocytes in chronic viral hepatitis. J. Exp. Med. 179, 841\u2013848 (1994).","journal-title":"J. Exp. Med."},{"key":"BFnm11011202_CR5","doi-asserted-by":"publisher","first-page":"917","DOI":"10.7326\/0003-4819-112-12-917","volume":"112","author":"GLA Bird","year":"1990","unstructured":"Bird, G.L.A., Sheron, N., Goka, J., Alexander, G.J. & Williams, R.S. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann. Intern. Med. 112, 917\u2013920 (1990).","journal-title":"Ann. Intern. Med."},{"key":"BFnm11011202_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0140-6736(88)90006-2","volume":"8602","author":"Y Muto","year":"1988","unstructured":"Muto, Y. et al. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 8602, 72\u201374 (1988).","journal-title":"Lancet"},{"key":"BFnm11011202_CR7","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/j.1572-0241.1999.01132.x","volume":"94","author":"KV Kowdley","year":"1999","unstructured":"Kowdley, K.V. TNF-\u03b1 in chronic hepatitis C: The smoking gun? Am. J. Gastroenterol. 94, 1132\u20131135 (1999).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnm11011202_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/B978-012498340-3\/50025-7","volume-title":"Cytokines","author":"R Beyaert","year":"1998","unstructured":"Beyaert, R. & Fiers, W. Tumor necrosis factor and lymphotoxin. in Cytokines. (eds. Mire-Sluis, A.R. & Thorpe, R.) 335\u2013360 (Academic Press, San Diego, 1998)."},{"key":"BFnm11011202_CR9","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/0008-8749(86)90025-0","volume":"100","author":"L Fransen","year":"1986","unstructured":"Fransen, L., Ruysschaert, M.R., Van der Heyden, J. & Fiers, W. Recombinant tumor necrosis factor: species specificity for a variety of human and murine transformed cell lines. Cell. Immunol. 100, 260\u2013267 (1986).","journal-title":"Cell. Immunol."},{"key":"BFnm11011202_CR10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/ijc.2910380521","volume":"38","author":"PGG Brouckaert","year":"1986","unstructured":"Brouckaert, P.G.G., Leroux\u2013Roels, G.G., Guisez, Y., Tavernier, J. & Fiers, W. In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma, on a syngeneic murine melanoma. Int. J. Cancer 38, 763\u2013769 (1986).","journal-title":"Int. J. Cancer"},{"key":"BFnm11011202_CR11","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4049\/jimmunol.154.3.1307","volume":"154","author":"M Leist","year":"1995","unstructured":"Leist, M., Gantner, F., Jilg, S. & Wendel, A. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J. Immunol. 154,1307\u20131316 (1995)","journal-title":"J. Immunol."},{"key":"BFnm11011202_CR12","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/hep.510260621","volume":"26","author":"Y Iimuro","year":"1997","unstructured":"Iimuro, Y., Gallucci, R.M., Luster, M.I., Kono, H. & Thurman, R.G. Antibodies to tumor necrosis factor \u03b1 attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26, 1530\u20131537 (1997).","journal-title":"Hepatology"},{"key":"BFnm11011202_CR13","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/rheumatology\/36.6.643","volume":"36","author":"FM Brennan","year":"1997","unstructured":"Brennan, F.M. et al. Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-\u03b1 (cA2) therapy. Br. J. Rheumat. 36, 643\u2013650 (1997).","journal-title":"Br. J. Rheumat."},{"key":"BFnm11011202_CR14","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1161\/01.CIR.99.24.3103","volume":"99","author":"TB Rajavashisth","year":"1999","unstructured":"Rajavashisth, T.B. et al. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Circulation 99, 3103\u20133109 (1999).","journal-title":"Circulation"},{"key":"BFnm11011202_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0092-8674(00)80064-1","volume":"99","author":"K Holmbeck","year":"1999","unstructured":"Holmbeck, K. et al. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99, 81\u201392 (1999).","journal-title":"Cell"},{"key":"BFnm11011202_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0092-8674(00)81169-1","volume":"93","author":"TH Vu","year":"1998","unstructured":"Vu, T.H. et al. MMP-9\/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411\u2013422 (1998).","journal-title":"Cell"},{"key":"BFnm11011202_CR17","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S0955-0674(98)80035-5","volume":"10","author":"SD Shapiro","year":"1998","unstructured":"Shapiro, S.D. Matrix metalloproteinase degradation of extracellular matrix: Biological consequences. Curr. Opin. Cell. Biol. 10, 602\u2013608 (1998).","journal-title":"Curr. Opin. Cell. Biol."},{"key":"BFnm11011202_CR18","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.1093\/emboj\/18.17.4645","volume":"18","author":"LR Lund","year":"1999","unstructured":"Lund, L.R. et al. Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J. 18, 4645\u20134656 (1999).","journal-title":"EMBO J."},{"key":"BFnm11011202_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1749-6632.1998.tb10116.x","volume":"857","author":"A Lochter","year":"1998","unstructured":"Lochter, A., Sternlicht M.D., Werb, Z. & Bissell, M.J. The significance of matrix metalloproteinases during early stages of tumor progression. Ann. NY Acad. Sci. 857, 180\u2013193 (1998).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnm11011202_CR20","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1126\/science.277.5334.2002","volume":"277","author":"RD Hautamaki","year":"1997","unstructured":"Hautamaki, R.D., Kobayashi, D.K., Senior, R.M. & Shapiro, S.D. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277, 2002\u20132004 (1997).","journal-title":"Science"},{"key":"BFnm11011202_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0168-8278(99)80007-5","volume":"30","author":"T Knittel","year":"1999","unstructured":"Knittel, T. et al. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: Regulation by TNF-\u03b1 and TGF-\u03b21. J. Hepatol. 30, 48\u201360 (1999).","journal-title":"J. Hepatol."},{"key":"BFnm11011202_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BFb0027661","volume":"71","author":"K Decker","year":"1974","unstructured":"Decker, K. & Keppler, D. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev. Physiol. Biochem. Pharmacol. 71, 77\u2013106 (1974).","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"BFnm11011202_CR23","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/11703","volume":"17","author":"E Koivunen","year":"1999","unstructured":"Koivunen, E. et al. Tumor targeting with a selective gelatinase inhibitor. Nature Biotechnol. 17, 768\u2013774 (1999).","journal-title":"Nature Biotechnol."},{"key":"BFnm11011202_CR24","first-page":"1051","volume":"261","author":"H Jaeschke","year":"1991","unstructured":"Jaeschke, H., Farhood, A. & Smith, W. Neutrophil-induced liver cell injury in endotoxin shock is a CD11b\/CD18-dependent mechanism. Am. J. Physiol. 261, 1051\u20131056 (1991).","journal-title":"Am. J. Physiol."},{"key":"BFnm11011202_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/hep.1840110205","volume":"11","author":"Y Shiratori","year":"1990","unstructured":"Shiratori, Y. et al. Role of endotoxin-responsive macrophages in hepatic injury. Hepatology 11, 183\u2013192 (1990).","journal-title":"Hepatology"},{"key":"BFnm11011202_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0092-8674(00)81009-0","volume":"98","author":"MD Sternlicht","year":"1999","unstructured":"Sternlicht, M.D. et al. The stromal proteinase MMP3\/stromelysin-1 promotes mammary carcinogenesis. Cell 98, 137\u2013146 (1999).","journal-title":"Cell"},{"key":"BFnm11011202_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/ng1297-439","volume":"17","author":"P Carmeliet","year":"1997","unstructured":"Carmeliet, P. et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nature Genet. 17, 439\u2013444 (1997).","journal-title":"Nature Genet."},{"key":"BFnm11011202_CR28","first-page":"378","volume-title":"Biologic Therapy of Cancer.","author":"RB Alexander","year":"1991","unstructured":"Alexander, R.B. & Rosenberg, S.A. Tumor necrosis factor: clinical applications. in Biologic Therapy of Cancer. (eds. DeVita, V.T. Jr, Hellman, S. & Rosenberg, S.A) 378\u2013392 (J.B. Lippincott, Philadelphia, 1991)."},{"key":"BFnm11011202_CR29","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1084\/jem.180.4.1571","volume":"180","author":"C Libert","year":"1994","unstructured":"Libert, C., Brouckaert, P. & Fiers, W. Protection by \u03b11-acid glycoprotein against tumor necrosis factor-induced lethality. J. Exp. Med. 180, 1571\u20131575 (1994).","journal-title":"J. Exp. Med."},{"key":"BFnm11011202_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1749-6632.1999.tb07674.x","volume":"878","author":"JS Skotnicki","year":"1999","unstructured":"Skotnicki, J.S. et al. Design and synthetic considerations of matrix metalloproteinase inhibitors. Ann NY Acad. Sci. 878, 61\u201372 (1999).","journal-title":"Ann NY Acad. Sci."},{"key":"BFnm11011202_CR31","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1021\/jm970404a","volume":"41","author":"M Yamamoto","year":"1998","unstructured":"Yamamoto, M. et al. Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: An examination of the subsite pocket. J. Med. Chem. 41, 1209\u20131217 (1998).","journal-title":"J. Med. Chem."},{"key":"BFnm11011202_CR32","first-page":"985","volume":"4","author":"R Giavazzi","year":"1998","unstructured":"Giavazzi, R. et al. Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts. Clin. Cancer Res. 4, 985\u2013992 (1998).","journal-title":"Clin. Cancer Res."},{"key":"BFnm11011202_CR33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1152\/ajpgi.2000.279.2.G245","volume":"279","author":"MJP Arthur","year":"2000","unstructured":"Arthur, M.J.P. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 279, 245\u2013249 (2000).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnm11011202_CR34","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1023\/A:1018898905478","volume":"43","author":"K Takenaka","year":"1998","unstructured":"Takenaka, K., Sakaida, I., Yasunaga, M. & Okita, K. Ultrastructural study of development of hepatic necrosis induced by TNF-\u03b1 and d-galactosamine. Dig. Dis. Sci. 43, 887\u2013892 (1998).","journal-title":"Dig. Dis. Sci."},{"key":"BFnm11011202_CR35","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1165\/ajrcmb.20.3.3311","volume":"20","author":"J Pugin","year":"1999","unstructured":"Pugin, J. et al. Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am. J. Respir. Cell. Mol. Biol. 20, 458\u2013464 (1999).","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"BFnm11011202_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01606425","volume":"423","author":"A Martinez-Hernandez","year":"1993","unstructured":"Martinez-Hernandez, A. & Amenta, P.S. The hepatic extracellular matrix. Virchows Archiv. A Pathol. Anat. 423, 1\u201311 (1993).","journal-title":"Virchows Archiv. A Pathol. Anat."},{"key":"BFnm11011202_CR37","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/j.1749-6632.1999.tb07774.x","volume":"878","author":"A Amour","year":"1999","unstructured":"Amour, A. et al. Inhibition of the metalloproteinase domain of mouse TACE. Ann. NY Acad. Sci. 878, 728\u2013731 (1999).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnm11011202_CR38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/370555a0","volume":"370","author":"AJ Gearing","year":"1994","unstructured":"Gearing, A.J. et al. Processing of tumour necrosis factor-\u03b1 precursor by metalloproteinases. Nature 370, 555\u2013557 (1994).","journal-title":"Nature"},{"key":"BFnm11011202_CR39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1101\/gad.14.2.163","volume":"14","author":"Q Yu","year":"2000","unstructured":"Yu, Q. & Stamenkovic, I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-\u03b2 and promotes tumor invasion and angiogenesis. Genes Dev. 14, 163\u2013176 (2000).","journal-title":"Genes Dev."},{"key":"BFnm11011202_CR40","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.4049\/jimmunol.161.7.3340","volume":"161","author":"U Schonbeck","year":"1998","unstructured":"Schonbeck, U., Mach, F. & Libby P. Generation of biologically active IL-1\u03b2 by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1\u03b2 processing. J. Immunol. 161, 3340\u20133346 (1998).","journal-title":"J. Immunol."},{"key":"BFnm11011202_CR41","first-page":"353","volume":"54","author":"WJ Murdoch","year":"1999","unstructured":"Murdoch, W.J. Plasmin-tumour necrosis factor interaction in the ovulatory process. J. Reprod. Fertil. Suppl. 54, 353\u2013358 (1999).","journal-title":"J. Reprod. Fertil. Suppl."},{"key":"BFnm11011202_CR42","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1083\/jcb.139.7.1861","volume":"139","author":"A Lochter","year":"1997","unstructured":"Lochter, A. et al. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol. 139, 1861\u20131872 (1997).","journal-title":"J. Cell Biol."},{"key":"BFnm11011202_CR43","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1002\/eji.1830240945","volume":"24","author":"C Libert","year":"1994","unstructured":"Libert, C. et al. Response of interleukin-6\u2013deficient mice to tumor necrosis factor-induced metabolic changes and lethality. Eur. J. Immunol. 24, 2237\u20132242 (1994).","journal-title":"Eur. J. Immunol."},{"key":"BFnm11011202_CR44","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.4049\/jimmunol.152.10.5041","volume":"152","author":"B Everaerdt","year":"1994","unstructured":"Everaerdt, B., Brouckaert, P. & Fiers, W. A recombinant interleukin-1 receptor antagonist protects against tumor necrosis factor-induced lethality in mice. J. Immunol. 152, 5041\u20135049 (1994).","journal-title":"J. Immunol."},{"key":"BFnm11011202_CR45","doi-asserted-by":"publisher","first-page":"22389","DOI":"10.1074\/jbc.272.36.22389","volume":"272","author":"T Itoh","year":"1997","unstructured":"Itoh, T. et al. Unaltered secretion of \u03b2-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J. Biol. Chem. 272, 22389\u201322392 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnm11011202_CR46","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/1529-0131(199801)41:1<110::AID-ART14>3.0.CO;2-G","volume":"41","author":"JS Mudgett","year":"1998","unstructured":"Mudgett, J.S. et al. Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum. 41, 110\u2013121 (1998).","journal-title":"Arthritis Rheum."},{"key":"BFnm11011202_CR47","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1073\/pnas.93.9.3942","volume":"93","author":"JM Shipley","year":"1996","unstructured":"Shipley, J.M., Wesselschmidt, R.L., Kobayashi, D.K., Ley, T.J. & Shapiro, S.D. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc. Natl. Acad. Sci. USA 93, 3942\u20133946 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm11011202_CR48","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.4049\/jimmunol.159.7.3555","volume":"159","author":"W Van Molle","year":"1997","unstructured":"Van Molle, W., C. Libert, W. Fiers & Brouckaert, P. \u03b11-Acid glycoprotein and \u03b11-antitrypsin inhibit TNF-induced but not anti-Fas-induced apoptosis of hepatocytes in mice. J. Immunol. 159, 3555\u20133561 (1997).","journal-title":"J. Immunol."},{"key":"BFnm11011202_CR49","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.4049\/jimmunol.163.10.5235","volume":"163","author":"W Van Molle","year":"1999","unstructured":"Van Molle, W. et al. Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins. J. Immunol. 163, 5235\u20135241 (1999).","journal-title":"J. Immunol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1101-1202.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1101-1202","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1101-1202.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:07:12Z","timestamp":1684447632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1101-1202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["BFnm11011202"],"URL":"https:\/\/doi.org\/10.1038\/nm1101-1202","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}